#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Macular telangiectasia Craniocerebral injury Amyotrophic lateral sclerosis Dupuytren's contracture Immunodeficiency Thrombotic microangiopathy Hepatoblastoma Acromegaly Cholangiosarcoma Tuberous sclerosis complex Albright's disease Hypophosphatasia Sickle cell anaemia Oesophageal squamous cell carcinoma stage III Aplastic anaemia More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome – Diagnostics Inclusion body myositis – Life with Disease Pulmonary sarcoidosis – Life with Disease Congenital hypotransferrinaemia – Trials in Disease KBG syndrome – Trials in Disease Splenic marginal zone lymphoma – Trials in Disease Ehlers-Danlos syndrome – Basic Information Synovial sarcoma – Basic Information Breast angiosarcoma – Diagnostics Ewing’s sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ertapenem Nicotine Resinate Ly3454738 Nadroparin Calcium Crizanlizumab VG801-2 Dexamethasone Cendakimab Folic Acid, Anhydrous Dorocubicel Trehalose Dihydrate (Ph.eur.) Ly3298176 Dirocaftor Siremadlin Alendronate Sodium Monohydrate Palonosetron Prednisone Acetate Belinostat Bendamustine Hydrochloride Mrna-3210 More therapies…

    Learn about Your Condition

    Prostatitis Escherichia coli Marfan's syndrome Rectal cancer Micrographic skin surgery Pericarditis Lupus nephritis Hypoparathyroidism Colon cancer metastatic Colour blindness Decreased appetite T-cell lymphoma Hereditary ataxia Triple positive breast cancer Neurodevelopmental disorder Metabolic surgery More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Safety and Efficacy of MaaT013 with Vancomycin in Children and Adolescents with Gastrointestinal Acute Graft‑versus‑Host Disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Graft versus host disease
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Vancomycin
    France Italy The Netherlands Spain

  • Carboplatin‑based drug combination for advanced non‑small cell lung cancer patients with interstitial lung disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIB
    • Interstitial lung disease
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Vinorelbine
    • Bevacizumab
    • Carboplatin
    France

  • Contraception study in women: comparing oral drospirenone‑only, drospirenone + ethinylestradiol, and drospirenone + estetrol tablets

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • DROSPIRENONE
    • Ethinylestradiol
    Finland

  • Effect of cladribine tablets on immune synapse in patients with relapsing multiple sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cladribine
    Greece

  • A Phase 3 Study Evaluating the Efficacy and Safety of Subcutaneous Nomlabofusp in Adults and Children with Friedreich’s Ataxia

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Friedreich’s ataxia
    France

  • Safety, tolerability and efficacy of topical human fibroblasts in patients with chronic refractory wounds (two-part study)

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • HUMAN FIBROBLASTS
    Italy
Previous Page
1 … 721 722 723 724 725 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!